Insights On CONTRACT PHARMA MANUFACTURING

  1. Flexible And Scalable Capacity That Grows With You 11/24/2025

    Explore flexible, globally compliant aseptic fill/finish services spanning clinical to commercial scales. Learn about handling various molecule types and dosage forms, supported by integrated development and regulatory services.

  2. Developments In OSD Manufacturing: What Biotechs Need To Know 11/24/2025

    Oral solid dose (OSD) manufacturing advances address poor solubility and HPAPI handling through innovations like advanced formulation, enhanced containment, and flexible digitalized suites.

  3. Human Performance In Pharma: Strengthening The Biotech Workforce 11/24/2025

    Transforming the pharma workforce requires strategic partnerships and a shift toward behavioral and operational readiness, moving beyond simple technical training to ensure performance and compliance.

  4. Extrusion-Based ASD Scale-Up: Performance Through Process Understanding 11/20/2025

    Explore the formulation and manufacturing considerations for amorphous solid dispersions (ASDs), with a focus on hot melt extrusion (HME) as a scalable and cost-effective technology option.

  5. Unlock Robust And Reliable Stability Data With The Right Partner 11/19/2025

    Stability testing is essential to ensuring your drug’s stability, potency, efficacy, and safety under different controlled conditions throughout development, manufacturing, and life cycle management.

  6. Accelerating A Complex Molecule From CLD To cGMP In 12 Months 11/19/2025

    Learn how to mitigate technical risk, implement parallel process development, and design custom purification strategies for highly sensitive novel modalities to accelerate to cGMP material.

  7. Seamless Onshoring From China-Based CDMO 11/19/2025

    Successfully mitigate geopolitical risk and maintain supply continuity. Learn how a large-scale manufacturing process was rapidly requalified in eight months to secure a clinical-stage biologic program.

  8. How One Biotech Company Is Accelerating The Drug Discovery Workflow 11/14/2025

    See how biotech innovation is accelerating drug discovery through AI, miniaturized workflows, and collaborative technologies to reshape how therapies are developed and delivered.

  9. Advanced Therapies Going Mainstream: Are We There Yet? 11/14/2025

    Advanced therapies are nearing mainstream adoption, with cell, mRNA, and oligonucleotide treatments expanding into broader indications. Learn what’s driving this shift and what manufacturers must do.

  10. Biologically Expressed vs. Synthetic GLP-1 Peptides 11/14/2025

    Selecting the right GLP-1 peptide manufacturing route determines the specific impurity profile and regulatory strategy. Robust analytical methods are essential for ensuring efficacy and patient safety.